Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever

  • J van Paassen
  • , MP Bauer
  • , MS (Mendi Sesmu) Arbous
  • , LG Visser
  • , J Schmidt-Chanasit
  • , S Schilling
  • , S Olschlager
  • , T Rieger
  • , P Emmerich
  • , C Schmetz
  • , F van den Berkmortel
  • , B van Hoek
  • , ND van Burgel
  • , Ab Osterhaus
  • , ACTM Vossen
  • , S Gunther
  • , JT van Dissel

Research output: Contribution to journalArticleAcademic

45 Citations (Scopus)

Abstract

A woman developed Marburg haemorrhagic fever in the Netherlands, most likely as a consequence of being exposed to virus-infected bats in the python cave in Maramagambo Forest during a visit to Uganda. The clinical syndrome was dominated by acute liver failure with secondary coagulopathy, followed by a severe systemic inflammatory response, multiorgan failure, and fatal cerebral oedema. A high blood viral load persisted during the course of the disease. The initial systemic inflammatory response coincided with peaks in interferon-gamma and tumour necrosis factor-a concentrations in the blood. A terminal rise in interleukin-6, placental growth factor (PlGF), and soluble vascular endothelial growth factor receptor-1 (sVEGF-R1) seemed to suggest an advanced pathophysiological stage of Marburg haemorrhagic fever associated with vascular endothelial dysfunction and fatal cerebral oedema. The excess of circulating sVEGF-R1 and the high sVEGF-R1:PlGF ratio shortly before death resemble pathophysiological changes thought to play a causative part in pre-eclampsia. Aggressive critical-care treatment with renal replacement therapy and use of the molecular absorbent recirculation system appeared able to stabilise-at least temporarily-the patient's condition.
Original languageUndefined/Unknown
Pages (from-to)635-642
Number of pages8
JournalLancet Infectious Diseases
Volume12
Issue number8
DOIs
Publication statusPublished - 2012

Research programs

  • EMC MM-04-27-01

Cite this